Label: PR BENZOYL PEROXIDE WASH- benzoyl peroxide wash lotion
-
Contains inactivated NDC Code(s)
NDC Code(s): 42546-145-16 - Packager: PruGen, Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated June 12, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
DESCRIPTION
DESCRIPTION:
PRTM Benzoyl Peroxide Wash is intended for topical administration and contains Benzoyl Peroxide for use in the treatment of acne vulgaris. Benzoyl Peroxide is an oxidizing agent that possesses antibacterial properties and is classified s a keratolytic. Benzoyl Peroxide (C14H10O4) is represented by the
following chemical structure:
O = C – O – O – C = OEach mL of PRTM Benzoyl Peroxide Wash contains 70 mg of Benzoyl Peroxide in an emulsion based formulation consisting of: aloe, carbomer 940, cetyl alcohol, disodium oleamido MEA-sulfosuccinate, disodium EDTA, glyceryl stearate/PEG-100 stearate, glycerin, green tea, laureth-12, magnesium aluminum silicate, propylene glycol, purified water, sodium coco-sulfate, sodium lauroamphoacetate, xanthan gum.
-
CLINICAL PHARMACOLOGY
CLINICAL PHARMACOLOGY:
The mechanism of action of Benzoyl Peroxide is not totally understood but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action. In addition, patients treated with Benzoyl Peroxide show a reduction in lipids and free fatty acids, and mild desquamation (drying and peeling activity) with simultaneous reduction in comedones and acne lesions. Little is known about the percutaneous penetration, metabolism, and excretion of Benzoyl Peroxide, although it has been shown that Benzoyl Peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by Benzoyl Peroxide in humans. - INDICATIONS & USAGE
- CONTRAINDICATIONS
-
WARNINGS AND PRECAUTIONS
WARNINGS:
When using this product, avoid unnecessary sun exposure and use a sunscreen.
PRECAUTIONS:
General: For external use only. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application. These preparations should not be used in or near the eyes or on mucous membranes. -
INFORMATION FOR PATIENTS
Information For Patients:
Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. Contact with any colored material (including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician. -
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
Carcinogensesis, Mutagenesis, Impairment of Fertility:
Data from several studies employing a strain of mice that is highly susceptible to developing cancer suggest that Benzoyl Peroxide acts as a tumor promoter. The clinical significance of these findings to humans is unknown. Benzoyl Peroxide has not been found to be mutagenic (Ames Test) and there are no published data indicating it impairs fertility. -
PREGNANCY
Pregnancy: Teratogenic Effects:
Pregnancy Category C: Animal reproduction studies have not been conducted with Benzoyl Peroxide. It is not known whether Benzoyl Peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl Peroxide should be used by a pregnant woman only if clearly needed. There are no available data on the effect of Benzoyl Peroxide on the later growth, development and functional maturation of the unborn child. - ADVERSE REACTIONS
-
OVERDOSAGE
OVERDOSAGE:
If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity. -
DOSAGE & ADMINISTRATION
DOSAGE AND ADMINISTRATION:
PRTM Benzoyl Peroxide Wash: Apply to affected areas once or twice a day, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather. Rinse thoroughly and pat dry. If excessive drying occurs, control by rinsing of cleanser sooner or using less often. - HOW SUPPLIED
- STORAGE AND HANDLING
- PRINCIPAL DISPLAY PANEL - 473 mL Bottle Box
-
INGREDIENTS AND APPEARANCE
PR BENZOYL PEROXIDE WASH
benzoyl peroxide wash lotionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42546-145 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Benzoyl Peroxide (UNII: W9WZN9A0GM) (Benzoyl Peroxide - UNII:W9WZN9A0GM) Benzoyl Peroxide 70 mg in 1 mL Inactive Ingredients Ingredient Name Strength aloe (UNII: V5VD430YW9) CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E) cetyl alcohol (UNII: 936JST6JCN) DISODIUM OLEAMIDO MONOETHANOLAMINE SULFOSUCCINATE (UNII: 5M1101WGSY) EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM) PEG-100 STEARATE (UNII: YD01N1999R) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) GLYCERIN (UNII: PDC6A3C0OX) GREEN TEA LEAF (UNII: W2ZU1RY8B0) laureth-12 (UNII: OAH19558U1) magnesium aluminum silicate (UNII: 6M3P64V0NC) propylene glycol (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) sodium coco-sulfate (UNII: 3599J29ANH) sodium lauroamphoacetate (UNII: SLK428451L) xanthan gum (UNII: TTV12P4NEE) Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:42546-145-16 1 in 1 BOX 10/26/2009 1 473 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 10/26/2009 Labeler - PruGen, Inc. (929922750) Establishment Name Address ID/FEI Business Operations PHARMASOL CORPORATION 065144289 MANUFACTURE(42546-145)